T1	Participants 52 75	three-year-old children
T2	Participants 534 573	6350 healthy infants by 2 months of age
T3	Participants 1006 1119	Children who met specified minimum criteria regarding the persistence of MEE became eligible for a clinical trial
T4	Participants 1366 1423	241 children who represented a spectrum of MEE experience
